DXR Stock Summary and Trading Ideas (Daxor - Closed End | NASDAQ:DXR)

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Daxor - Closed End trades on the NASDAQ stock market under the symbol DXR.

As of May 2, 2024, DXR stock price was flat at $9.80 with 7 million shares trading.

DXR has a market cap of $46.40 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, DXR stock traded as high as $15.46 and as low as $7.11.

The top ETF exchange traded funds that DXR belongs to (by Net Assets): VTI.

DXR stock has underperformed the market in the last year with a return of -13.3%, while SPY returned +22.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DXR shares. However, DXR has outperformed the market in the last 3 month and 2 week periods, returning +17.4% and +1.9%, while SPY returned +3.1% and +0.5%, respectively. This indicates DXR has been having a stronger performance recently.

DXR support price is $9.48 and resistance is $10.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DXR stock will trade within this expected range on the day.